See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Teaching Aids for Health Educators

Barbara George

Teaching Aids for Health Educators

VITAZEST® Vitamin and Fruit Enriched Water

Roy Alcalay

VITAZEST® Vitamin and Fruit Enriched Water

Continuous Glucose Monitoring with DEXCOM's

Deb Ruppert

Continuous Glucose Monitoring with DEXCOM's "The Seven"

Novo Nordisk Archives

Novo Nordisk

Page 2
Brown, White and Beige: Not in Fashion But in Fat

To help stem the obesity epidemic, researchers are looking at how certain hormones act on fat cells. Scientists know that "white" fat cells store fat while "brown" fat cells not only store fat but also turn it into energy, a process that goes awry in obesity.

Comments 0 comments - Dec 23, 2012 - * * * * *

Behind the Wheel, But Still in Control

Last May, 24-year-old Charlie Kimball was in Car #35, taking Turn 3 at the Indianapolis Motor Speedway during the Firestone Freedom 100. He was in radio contact with his pit crew, who informed him that he had a headwind coming out of the turn and onto the 5/8 mile "straight." Charlie kept an eye on the car next to him, moving closer and beginning to crowd it on the inside. Having raced professionally for six years, he knew that he had to make a move, and soon. He shifted into sixth gear and accelerated.

Comments 1 comment - Dec 4, 2012 - * * * * *

Lilly Says Its New Injectible Outperforms 3 Popular Diabetes Drugs

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

Comments 0 comments - Nov 5, 2012 - * * * * *

Paula Deen: Cooking Up a New Life With Diabetes

Paula Deen, a celebrity Southern chef known for her unrestrained love of butter and sugar, is no stranger to the media. She received a flurry of bad press recently when she revealed that she had been diagnosed with type 2 diabetes three years earlier. Shortly thereafter, she became a spokesperson for Novo Nordisk's Victoza. Following these developments, some critics said that she was a poor role model. 

Comments 2 comments - Aug 28, 2012 - * * * * *

Diabetes on the Rise in Saudi Arabia

Diabetes is increasingly taking hold in Saudi Arabia and other countries in the Middle East.  According to Dr. Ala Alwan, assistant director general for noncommunicable diseases and mental health at the World Health Organization (WHO), the problem is already vast and is increasing at an alarming rate.

Comments 0 comments - May 29, 2012 - * * * * *

Insulin degludec

Novo Nordisk's new variety of long-lasting insulin, insulin degludec, reduces low blood sugars while improving overall control, according to a pair of studies published in the prestigious journal The Lancet on April 27.

Comments 0 comments - May 8, 2012 - * * * * *

FDA Says Levemir OK for Pregnant Women

The U.S. Food and Drug Administration says that Levemir is safe for use by pregnant women and does not increase the risk of harm to children in the womb.

Comments 0 comments - Apr 4, 2012 - * * * * *

Hypoglycemia Affects Productivity at Work

A survey of type 1 and type 2 diabetes patients in the United States, United Kingdom, France, and Germany indicates that more than one in every five have arrived late at work or not shown up at all because of a hypoglycemic episode the night before.

Comments 17 comments - Feb 21, 2012 - * * * * *

FDA Gives Long-Awaited Nod to Amylin’s Bydureon

After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February. Amylin says that its wholesale price will be about $4,200 a year.

Comments 2 comments - Feb 3, 2012 - * * * * *

DiabetesSisters’ National Conference Set for May 18-20 in Raleigh, NC

RALEIGH, NC- DiabetesSisters is pleased to announce that registration for the 2012 Weekend for Women Conference opened on January 1, 2012, at 8 AM. The conference, a revolutionary weekend designed specifically for women with diabetes, will take place Friday, May 18, through Sunday, May 20, 2012, at the Marriott City Center in downtown Raleigh.

Comments 0 comments - Jan 24, 2012 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.